224 related articles for article (PubMed ID: 21825282)
1. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
[TBL] [Abstract][Full Text] [Related]
2. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.
Addington J; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Santesteban-Echarri O; Woods SW
Psychol Med; 2019 Jul; 49(10):1670-1677. PubMed ID: 30176955
[TBL] [Abstract][Full Text] [Related]
3. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
[TBL] [Abstract][Full Text] [Related]
5. Course of clinical high-risk states for psychosis beyond conversion.
Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
[TBL] [Abstract][Full Text] [Related]
7. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
9. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
[TBL] [Abstract][Full Text] [Related]
10. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
11. Coping styles of individuals at clinical high risk for developing psychosis.
Jalbrzikowski M; Sugar CA; Zinberg J; Bachman P; Cannon TD; Bearden CE
Early Interv Psychiatry; 2014 Feb; 8(1):68-76. PubMed ID: 23164368
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
[TBL] [Abstract][Full Text] [Related]
13. Anxiety in youth at clinical high risk for psychosis.
McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
[TBL] [Abstract][Full Text] [Related]
14. Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis.
Simon AE; Borgwardt S; Riecher-Rössler A; Velthorst E; de Haan L; Fusar-Poli P
Psychiatry Res; 2013 Oct; 209(3):266-72. PubMed ID: 23871169
[TBL] [Abstract][Full Text] [Related]
15. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
[TBL] [Abstract][Full Text] [Related]
16. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis.
Bearden CE; Wu KN; Caplan R; Cannon TD
J Am Acad Child Adolesc Psychiatry; 2011 Jul; 50(7):669-80. PubMed ID: 21703494
[TBL] [Abstract][Full Text] [Related]
17. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
[TBL] [Abstract][Full Text] [Related]
18. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
Lunsford-Avery JR; Gonçalves BDSB; Brietzke E; Bressan RA; Gadelha A; Auerbach RP; Mittal VA
Schizophr Res; 2017 Nov; 189():37-42. PubMed ID: 28169087
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
[TBL] [Abstract][Full Text] [Related]
20. A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China.
Li H; Zhang T; Xu L; Tang Y; Cui H; Wei Y; Tang X; Woodberry KA; Shapiro DI; Li C; Seidman LJ; Wang J
Schizophr Res; 2018 Jul; 197():509-515. PubMed ID: 29287626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
